Sort
46,585 grants matching “heart failure”
Development of a Total Artificial Lung
$821,764Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2007 · HL
Metabolic effects and mechanisms for heart failure in South Asians
$821,729Alka M Kanaya · University Of California, San Francisco · R01 · FY2025 · HL
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes
$821,720Alessandro Doria · Joslin Diabetes Center · R01 · FY2022 · HL
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
$821,439Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
$821,439Thomas Weber · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Cell-free DNA Methylation Patterns and Mitochondrial Therapeutics in a Rodent Model of Organophosphate Poisoning
$821,373David H Jang · University Of Pennsylvania · R01 · FY2025 · ES
Brain-immune crosstalk in myocardial infarction
$821,333Wolfram Christian Poller · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - CORE STUDY OPERATIONS
$821,233Aaron Folsom · University Of Minnesota · N01 · FY2017 · HL
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$820,853Josef Coresh · Johns Hopkins University · N01 · FY2020 · HL
1/2 Self-directed mobile adaptive coping skills intervention to improve psychological distress symptoms among cardiorespiratory failure survivors: the Blueprint RCT
$820,823Christopher Ethan Cox · Duke University · UG3 · FY2024 · HL
Multi-isotope Hybrid PET/CT Imaging of Peripheral Artery Disease in Diabetes
$820,737Albert J Sinusas · Yale University · R01 · FY2024 · HL
Novel PET/CT and Treatment Strategies to reduce PTS following DVT
$820,597Farouc Amin Jaffer · Massachusetts General Hospital · R01 · FY2019 · HL
Melanocortin Ligands in Disease Cachexia
$820,563Kenneth Allen Gruber · Tensive Controls, Inc. · R44 · FY2013 · CA
Cardiac Growth and Function Trajectories after Preterm Birth
$819,962Kara N Goss · Ut Southwestern Medical Center · R01 · FY2023 · HL
Vascular Dysfunction in Myocardial Ischemia and Metabolic Syndrome
$819,895Frank W Sellke · Rhode Island Hospital · R01 · FY2023 · HL
Developing and validating race-specific cardiomyopathy risk prediction models in African American survivors of childhood cancer
$819,860Yadav Sapkota · St. Jude Children'S Research Hospital · R01 · FY2024 · HL
Molecular mismatch as a marker for immunologic risk in heart transplant recipients
$819,532Bonnie Elizabeth Lonze · New York University School Of Medicine · R01 · FY2025 · HL
Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function
$819,520Peter S Rabinovitch · University Of Washington · R56 · FY2017 · AG
2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
$819,482Hrishikesh Chakraborty · Duke University · U24 · FY2024 · HL
Predicting and Monitoring for Cardiac Toxicity in Pediatric AML
$819,404Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2023 · HL
Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms
$819,340Joseph C Wu · Stanford University · P01 · FY2013 · GM
Hypertension and Cardiorenal Research Training Program
$819,168Joey P. Granger · University Of Mississippi Med Ctr · T32 · FY2025 · HL
Pulmonary microvascular perfusion in the Multi-Ethnic Study of Atherosclerosis
$819,116R Graham Barr · Columbia University Health Sciences · R01 · FY2016 · HL
Glucose patterns and clinical outcomes in the Dallas Heart Study: A pathway to precision diabetes
$819,091Elizabeth Selvin · Johns Hopkins University · R01 · FY2025 · DK
Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation
$819,070Moore Benjamin Shoemaker · Vanderbilt University Medical Center · R01 · FY2024 · HL